Max Yan
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Breast Cancer Treatment Studies 6
- Genetics 7
- BRCA gene mutations in cancer 7
- Glioma Diagnosis and Treatment 1
- Co-authors
- Stephen B. Fox (7 shared papers)Catriona M. McNeil (2 shared papers)Sandra A O'Toole (2 shared papers)Ewan K.A. Millar (2 shared papers)Robert L. Sutherland (2 shared papers)David J. Byrne (2 shared papers)Nicholas Jene (1 shared paper)Gaynor J. Bates (1 shared paper)
- Journals
- Pathology (4 papers)Breast Cancer Research (4 papers)Breast Cancer Research and Treatment (3 papers)BMC Cancer (2 papers)Nature Medicine (1 paper)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Max Yan
17 papers receiving 2.3k citations
Max Yan's Hit Papers
Peers
Comparison fields: 5 of 66
- Cancer Research 581
- Oncology 781
- Genetics 737
- Molecular Biology 447
- Pathology and Forensic Medicine 107
Countries citing papers authored by Max Yan
This map shows the geographic impact of Max Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Yan more than expected).
Fields of papers citing papers by Max Yan
This network shows the impact of papers produced by Max Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Yan. The network helps show where Max Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers Hit paper breakdown → | 2009 | 1164 |
| 2 | Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1 / 2 (CIMBA) Hit paper breakdown → | 2012 | 538 |
| 3 | 2011 | 163 | |
| 4 | 2011 | 105 | |
| 5 | 2011 | 88 | |
| 6 | 2009 | 83 | |
| 7 | 2010 | 50 | |
| 8 | 2012 | 35 | |
| 9 | 2010 | 33 | |
| 10 | 2006 | 18 | |
| 11 | 2015 | 12 | |
| 12 | 2014 | 7 | |
| 13 | 2023 | 7 | |
| 14 | 2007 | 3 | |
| 15 | 2007 | 2 | |
| 16 | 2009 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2019 | 0 |
About Max Yan
Max Yan is a scholar working on Cancer Research, Genetics, Neurology, Pathology and Forensic Medicine and Oncology, having authored 18 papers that have together received 2.3k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (7 papers), Breast Cancer Treatment Studies (6 papers), Autoimmune Neurological Disorders and Treatments (2 papers), Breast Lesions and Carcinomas (1 paper), Glioma Diagnosis and Treatment (1 paper), Otitis Media and Relapsing Polychondritis (1 paper), Cancer Cells and Metastasis (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Cancer Research (581 citations), Oncology (781 citations), Genetics (737 citations), Molecular Biology (447 citations) and Pathology and Forensic Medicine (107 citations). Max Yan has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Stephen B. Fox, Catriona M. McNeil, Sandra A O'Toole, Ewan K.A. Millar, Robert L. Sutherland, David J. Byrne, Nicholas Jene, Gaynor J. Bates, Alison H. Banham and Adrian L. Harris. Their work appears in journals such as Pathology, Breast Cancer Research, Breast Cancer Research and Treatment, BMC Cancer and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.